Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
Clinical trial NCT04993885 · RECRUITING
Trial details
- NCT number
- NCT04993885
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2024-07-31
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.